Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,862.00p
   
  • Change Today:
      17.00p
  • 52 Week High: 2,088.00
  • 52 Week Low: 1,722.50
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 40,600
  • Market Cap: £4,131.53m
  • RiskGrade: 125
  • Beta: 0.53

Regulatory News

Outcome of Audit Tender Process 07-Nov-2024 15:30 RNS
Trading Statement 07-Nov-2024 07:00 RNS
2024 Annual General Meeting Update Statement 24-Oct-2024 07:00 RNS
Block listing Interim Review 01-Oct-2024 09:45 RNS
Director/PDMR Shareholding 24-Sep-2024 10:09 RNS
Hikma completes Xellia acquisition 10-Sep-2024 07:00 RNS
Director/PDMR Shareholding 13-Aug-2024 09:39 RNS
Half-year Report 08-Aug-2024 07:00 RNS
Director Declaration 29-Jul-2024 16:08 RNS
Notice of Results 15-Jul-2024 07:00 RNS
Total Voting Rights 01-Jul-2024 14:47 RNS
Director Declaration 27-Jun-2024 13:47 RNS
Hikma acquires Xellia’s assets 17-Jun-2024 07:00 RNS
Director/PDMR Shareholding 05-Jun-2024 14:53 RNS
Director/PDMR Shareholding 09-May-2024 09:49 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,862.00p
Change Today 17.00p
% Change 0.92 %
52 Week High 2,088.00
52 Week Low 1,722.50
Volume 40,600
Shares Issued 221.89m
Market Cap £4,131.53m
Beta 0.53
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.51% below the market average41.51% below the market average41.51% below the market average41.51% below the market average41.51% below the market average
8% below the sector average8% below the sector average8% below the sector average8% below the sector average8% below the sector average
Price Trend
39.88% above the market average39.88% above the market average39.88% above the market average39.88% above the market average39.88% above the market average
75.51% above the sector average75.51% above the sector average75.51% above the sector average75.51% above the sector average75.51% above the sector average
Income
22.76% above the market average22.76% above the market average22.76% above the market average22.76% above the market average22.76% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
27.91% below the market average27.91% below the market average27.91% below the market average27.91% below the market average27.91% below the market average
5.88% above the sector average5.88% above the sector average5.88% above the sector average5.88% above the sector average5.88% above the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Interim Final
Ex-Div 15-Aug-24 21-Mar-24
Paid 20-Sep-24 03-May-24
Amount 32.00¢ 47.00¢

Trades for 21-Nov-2024

Time Volume / Share Price
13:16 46 @ 1,862.00p
13:13 5 @ 1,862.00p
13:13 89 @ 1,862.00p
13:13 48 @ 1,862.00p
13:13 63 @ 1,862.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page